57. Kongress der Deutschen Gesellschaft für Pneumologie und Beatmungsmedizin e.V.
Leipzig,
2.–5. 3. 2016
Kongresspräsident: Prof. Dr. med. Hubert Wirtz, Leipzig – Kongresssekretär: Dr. med. Jens Bräunlich, Leipzig
P514
Reck, M;
Smit, EF;
Garon, E;
Cappuzzo, F;
Bidoli, P;
Cohen, R;
Gao, L;
Ernest II, CS;
Lee, P;
Zimmermann, A;
Ferry, D;
Treat, J;
Melemed, A;
Perol, M:
Exposure Response-Analyse von Ramucirumab (RAM) in der randomisierten, doppelblinden Phase III Studie REVEL (Docetaxel [DOC] versus DOC und RAM) in der Zweitlinienbehandlung des metastasierten Nicht-Kleinzelligen Lungenkarzinoms (NSCLC)
FREE ACCESS
P490
Dickgreber, N;
Yang, JCH;
Ahn, MJ;
Halmos, B;
Hirsh, V;
Hochmair, M;
Levy, B;
de Marinis, F;
Mok, T;
O'Byrne, K;
Okamoto, I;
Schuler, M;
Sebastian, M;
Shah, R;
Tan, EH;
Yamamoto, N;
Märten, A;
Massey, D;
Wind, S;
Carbone, D:
Influence of dose adjustment on afatinib safety and efficacy in patients (pts) with advanced EGFR mutation-positive (EGFRm+) non-small cell lung cancer (NSCLC)
FREE ACCESS
P132
Griesinger, F;
Lüers, A;
Falk, M;
Conradi, I;
Reinhardt, M;
Kluge, A;
Willborn, K;
Prenzel, R;
Scriba, DC;
Henke, R;
Eberhardt, W;
Hallas, C;
Tiemann, M:
Intercalated TKI and chemotherapy induction in EGFR mt+ NSCLC stage IIIA and IIIB: report of 3 cases with complete pathologic remission in mediastinal lymph nodes
FREE ACCESS
P233
Griesinger, F;
Sebastian, M;
Serke, M;
Grohé, C;
Hillejan, L;
Passlick, B;
Reinmuth, N;
Graeven, U;
Radke, S;
Karatas, A;
Tiemann, M;
Overbeck, T:
Induction therapy with intercalated TKI and chemotherapy in NSCLC with activating EGFR mutation in stages II-IIIB: NeoIntercal
FREE ACCESS
P79
Pawel, J von;
Kraff, S;
Fischer, JR;
Eberhardt, W;
Gauler, T;
Müller, L;
Reinmuth, N;
Reck, M;
Kimmich, M;
Mayer, F;
Kopp, HG;
Behringer, DM;
Ko, YD;
Frueh, M;
Hilger, RA;
Roessler, M;
Moritz, B;
Jaehde, U;
Joerger, M:
Open-label, randomized study of individualized, pharmacokinetically (PK)-guided dosing of paclitaxel combined with carboplatin in advanced Non-Small Cell Lung Cancer (NSCLC) patient
FREE ACCESS
